SOTERA HEALTH CO (SHC) Forecast, Price Target & Analyst Ratings

NASDAQ:SHC • US83601L1026

Current stock price

13.71 USD
-0.14 (-1.01%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SOTERA HEALTH CO (SHC).

Forecast Snapshot

Consensus Price Target

Price Target
$20.85
+ 52.05% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 29, 2026
Period
Q1 / 2026
EPS Estimate
$0.18
Revenue Estimate
273.48M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
84.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$20.85
Upside
+ 52.05%
From current price of $13.71 to mean target of $20.85, Based on 15 analyst forecasts
Low
$16.16
Median
$20.40
High
$25.20

Price Target Revisions

1 Month
0.00%
3 Months
7.97%

Price Target Summary

15 Wall Street analysts provided a forecast for the next 12 months for SHC. The average price target is 20.85 USD. This implies a price increase of 52.05% is expected in the next year compared to the current price of 13.71.
The average price target has been revised upward by 7.97% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

SHC Current Analyst RatingSHC Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

SHC Historical Analyst RatingsSHC Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10

Analyst Ratings Consensus

ChartMill Buy Consensus
84.00%
SHC was analyzed by 15 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about SHC.
In the previous month the buy percentage consensus was at a similar level.
SHC was analyzed by 15 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-24CitigroupMaintains Buy -> Buy
2026-01-09RBC CapitalReiterate Outperform
2026-01-09Piper SandlerUpgrade Neutral -> Overweight
2025-12-18William BlairInitiate Outperform
2025-11-13BMO CapitalInitiate Outperform
2025-11-05BarclaysMaintains Overweight -> Overweight
2025-11-05JP MorganMaintains Neutral -> Neutral
2025-11-05Piper SandlerMaintains Neutral -> Neutral
2025-10-02BarclaysMaintains Overweight -> Overweight
2025-06-24BarclaysMaintains Overweight -> Overweight
2025-05-05Goldman SachsUpgrade Neutral -> Buy
2025-04-23Piper SandlerMaintains Neutral -> Neutral
2025-04-10BarclaysMaintains Overweight -> Overweight
2025-02-28BarclaysMaintains Overweight -> Overweight
2025-02-18BarclaysMaintains Overweight -> Overweight
2024-11-21RBC CapitalReiterate Outperform -> Outperform
2024-11-06CitigroupMaintains Buy -> Buy
2024-08-06RBC CapitalReiterate Outperform -> Outperform
2024-08-06BarclaysMaintains Overweight -> Overweight
2024-05-21Piper SandlerInitiate Neutral
2024-04-10BarclaysMaintains Overweight -> Overweight
2024-04-03CitigroupUpgrade Neutral -> Buy
2024-03-25JefferiesUpgrade Hold -> Buy
2024-03-11RBC CapitalReiterate Outperform -> Outperform
2024-03-04RBC CapitalReiterate Outperform -> Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 29, 2026
Period
Q1 / 2026
EPS Estimate
$0.18
Revenue Estimate
273.48M
Revenue Q2Q
7.45%
EPS Q2Q
25.96%
Number of Analysts
11

Next Earnings Revisions

Revenue (1 Month)
-0.47%
Revenue (3 Months)
-0.67%
EPS (1 Month)
0.06%
EPS (3 Months)
0.25%

Next Earnings Summary

SHC is expected to report earnings on 4/29/2026. The consensus EPS estimate for the next earnings is 0.18 USD and the consensus revenue estimate is 273.48M USD.
The next earnings revenue estimate has been revised downward by 0.67% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
SHC revenue by date.SHC revenue by date.
1.049B
4.54%		1.1B
4.88%		1.164B
5.74%		1.251B
7.51%		1.326B
6.00%		1.406B
6.03%		1.507B
7.18%		1.65B
9.49%
EBITDA
YoY % growth
SHC ebitda by date.SHC ebitda by date.
434.617M
10.34%		461.263M
6.13%		498.74M
8.12%		641.45M
28.61%		682.09M
6.34%		725.77M
6.40%		785.78M
8.27%		N/A
EBIT
YoY % growth
SHC ebit by date.SHC ebit by date.
276.692M
11.43%		297.626M
7.57%		362.034M
21.64%		538.43M
48.72%		574.51M
6.70%		N/AN/AN/A
Operating Margin
SHC operating margin by date.SHC operating margin by date.
26.37%27.05%31.11%43.04%43.33%N/AN/AN/A
EPS
YoY % growth
SHC eps by date.SHC eps by date.
0.81
-16.49%		0.70
-13.58%		0.86
22.86%		0.97
13.17%		1.06
8.64%		1.17
10.58%		1.30
11.43%		N/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		0.18
25.96%		0.25
24.18%		0.27
5.61%		0.27
3.53%		0.21
16.65%		0.27
8.71%		0.30
7.65%		0.30
9.94%
Revenue
Q2Q % growth		273.48M
7.45%		317.67M
7.93%		328.81M
5.62%		327.37M
7.89%		293.54M
7.34%		335.07M
5.48%		347.66M
5.73%		343.96M
5.07%
EBITDA
Q2Q % growth		132.71M
35.63%		162.02M
-1.36%		173.74M
-19.32%		171.28M
-29.25%		147.46M
11.11%		171.93M
6.12%		182.8M
5.21%		174.5M
1.88%
EBIT
Q2Q % growth		106.51M
86.72%		134.86M
52.50%		151.27M
36.06%		133.43M
26.61%		121.2M
13.79%		145.44M
7.85%		155.54M
2.82%		147.46M
10.51%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

SHC Yearly Revenue VS EstimatesSHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
SHC Yearly EPS VS EstimatesSHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.2 0.4 0.6 0.8 1

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
10.78%
EPS Next 5 Year
10.94%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
6.29%
Revenue Next 5 Year
7.10%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
13.16%
EBIT Next 5 Year
11.92%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

SOTERA HEALTH CO / SHC Forecast FAQ

What is the price target for SHC stock?

15 analysts have analysed SHC and the average price target is 20.85 USD. This implies a price increase of 52.05% is expected in the next year compared to the current price of 13.71.

When does SOTERA HEALTH CO (SHC) report earnings?

SOTERA HEALTH CO (SHC) will report earnings on 2026-04-29, before the market open.

What are the consensus estimates for SHC stock next earnings?

The consensus EPS estimate for the next earnings of SOTERA HEALTH CO (SHC) is 0.18 USD and the consensus revenue estimate is 273.48M USD.

How do analysts rate SOTERA HEALTH CO (SHC)?

The consensus rating for SOTERA HEALTH CO (SHC) is 84 / 100 . This indicates that analysts generally have a positive outlook on the stock.